Statistical evidence from meta-analysis of VIVIAD and VIVA-MIND enables efficient design of Phase 2b study in diabetic kidney disease (DKD), ideally suited to evaluate varoglutamstat in the intended ...

If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.